Cortical abnormalities in bipolar disorder: an MRI analysis of 6503 individuals from the ENIGMA Bipolar Disorder Working Group.
Hibar DP., Westlye LT., Doan NT., Jahanshad N., Cheung JW., Ching CRK., Versace A., Bilderbeck AC., Uhlmann A., Mwangi B., Krämer B., Overs B., Hartberg CB., Abé C., Dima D., Grotegerd D., Sprooten E., Bøen E., Jimenez E., Howells FM., Delvecchio G., Temmingh H., Starke J., Almeida JRC., Goikolea JM., Houenou J., Beard LM., Rauer L., Abramovic L., Bonnin M., Ponteduro MF., Keil M., Rive MM., Yao N., Yalin N., Najt P., Rosa PG., Redlich R., Trost S., Hagenaars S., Fears SC., Alonso-Lana S., van Erp TGM., Nickson T., Chaim-Avancini TM., Meier TB., Elvsåshagen T., Haukvik UK., Lee WH., Schene AH., Lloyd AJ., Young AH., Nugent A., Dale AM., Pfennig A., McIntosh AM., Lafer B., Baune BT., Ekman CJ., Zarate CA., Bearden CE., Henry C., Simhandl C., McDonald C., Bourne C., Stein DJ., Wolf DH., Cannon DM., Glahn DC., Veltman DJ., Pomarol-Clotet E., Vieta E., Canales-Rodriguez EJ., Nery FG., Duran FLS., Busatto GF., Roberts G., Pearlson GD., Goodwin GM., Kugel H., Whalley HC., Ruhe HG., Soares JC., Fullerton JM., Rybakowski JK., Savitz J., Chaim KT., Fatjó-Vilas M., Soeiro-de-Souza MG., Boks MP., Zanetti MV., Otaduy MCG., Schaufelberger MS., Alda M., Ingvar M., Phillips ML., Kempton MJ., Bauer M., Landén M., Lawrence NS., van Haren NEM., Horn NR., Freimer NB., Gruber O., Schofield PR., Mitchell PB., Kahn RS., Lenroot R., Machado-Vieira R., Ophoff RA., Sarró S., Frangou S., Satterthwaite TD., Hajek T., Dannlowski U., Malt UF., Arolt V., Gattaz WF., Drevets WC., Caseras X., Agartz I., Thompson PM., Andreassen OA.
Despite decades of research, the pathophysiology of bipolar disorder (BD) is still not well understood. Structural brain differences have been associated with BD, but results from neuroimaging studies have been inconsistent. To address this, we performed the largest study to date of cortical gray matter thickness and surface area measures from brain magnetic resonance imaging scans of 6503 individuals including 1837 unrelated adults with BD and 2582 unrelated healthy controls for group differences while also examining the effects of commonly prescribed medications, age of illness onset, history of psychosis, mood state, age and sex differences on cortical regions. In BD, cortical gray matter was thinner in frontal, temporal and parietal regions of both brain hemispheres. BD had the strongest effects on left pars opercularis (Cohen's d=-0.293; P=1.71 × 10(-21)), left fusiform gyrus (d=-0.288; P=8.25 × 10(-21)) and left rostral middle frontal cortex (d=-0.276; P=2.99 × 10(-19)). Longer duration of illness (after accounting for age at the time of scanning) was associated with reduced cortical thickness in frontal, medial parietal and occipital regions. We found that several commonly prescribed medications, including lithium, antiepileptic and antipsychotic treatment showed significant associations with cortical thickness and surface area, even after accounting for patients who received multiple medications. We found evidence of reduced cortical surface area associated with a history of psychosis but no associations with mood state at the time of scanning. Our analysis revealed previously undetected associations and provides an extensive analysis of potential confounding variables in neuroimaging studies of BD.Molecular Psychiatry advance online publication, 2 May 2017; doi:10.1038/mp.2017.73.